Market shaping goal indicators

in page functions

To shape markets for vaccines and other immunisation products

Sufficient and uninterrupted supply

What we measure: number of Gavi vaccine markets with sufficient and uninterrupted supply of appropriate vaccines.


Cost of fully vaccinating a child with pentavalent, pneumococcal and rotavirus vaccines

What we measure: change in the weighted average vaccine price per child to fully vaccinate him or her with pentavalent, pneumococcal and rotavirus vaccines.


Innovation

What we measure: the number of vaccine products with improved characteristics procured as compared to the baseline year.

This indicator uses straightforward, objective criteria, published by WHO, the Alliance partner responsible for technical guidance on vaccines. The indicator includes all antigens supported by Gavi.


Healthy market dynamics

What we measure: the number of Gavi vaccine markets with moderate or high healthy market dynamics. We rate this in terms of:

  • high
  • moderate
  • low
  • no healthy market dynamics.

 

US$ 1 = US$ 18

A study in Health Affairs covering 73 Gavi-supported countries over the 2011–2020 period shows that, for every US$ 1 spent on immunisation, US$ 18 are saved in healthcare costs, lost wages and lost productivity due to illness. If we take into account the broader benefits of people living longer, healthier lives, the return on investment rises to US$ 48 per US$ 1 spent.

Ozawa S, Clark S, Portnoy A et al. Return on investment from childhood immunizations in low- and middle-income countries, 2011-20, Health Affairs 2016

More facts...

close icon

modal window here